|
ZNF33B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.880600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.460200E-03 |
| Normal-vs-Stage2 |
8.513600E-01 |
| Normal-vs-Stage3 |
8.993600E-02 |
| Normal-vs-Stage4 |
1.342210E-02 |
| Stage1-vs-Stage2 |
1.937020E-01 |
| Stage1-vs-Stage3 |
1.992410E-04 |
| Stage1-vs-Stage4 |
3.7979999999993E-05 |
| Stage2-vs-Stage3 |
2.137600E-01 |
| Stage2-vs-Stage4 |
9.314000E-02 |
| Stage3-vs-Stage4 |
4.664400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.707600E-01 |
| Normal-vs-AfricanAmerican |
3.688800E-01 |
| Normal-vs-Asian |
9.240400E-01 |
| Caucasian-vs-AfricanAmerican |
2.389600E-01 |
| Caucasian-vs-Asian |
9.940800E-01 |
| AfricanAmerican-vs-Asian |
6.572200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.009800E-01 |
| Normal-vs-Female |
8.463600E-01 |
| Male-vs-Female |
4.436800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.066000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.957000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.951200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.198000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.210600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.096600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.839800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.359200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.023200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.933000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.778430E-02 |
| Normal-vs-Grade 2 |
1.969410E-04 |
| Normal-vs-Grade 3 |
4.165800E-01 |
| Normal-vs-Grade 4 |
2.73590039512328E-11 |
| Grade 1-vs-Grade 2 |
3.400400E-01 |
| Grade 1-vs-Grade 3 |
6.935100E-03 |
| Grade 1-vs-Grade 4 |
3.94989996266304E-09 |
| Grade 2-vs-Grade 3 |
2.09329999999452E-05 |
| Grade 2-vs-Grade 4 |
<1E-12 |
| Grade 3-vs-Grade 4 |
3.35280003760374E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.82790002315414E-09 |
| Normal-vs-ccB subtype |
4.30049999999849E-06 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.491000E-01 |
| Normal-vs-N1 |
2.18259999995585E-06 |
| N0-vs-N1 |
3.424000E-04 |
|
|
